Clinical Trial Update: Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing Pegasys plus entecavir, entecavir alone, and Pegasys alone in patients with HBeAg-negative chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN